Liver/Biliary Disorders News

There was an 81% increase in alcohol-associated hepatitis admissions within the first year of the COVID-19 pandemic and resulted in a significant increase in liver transplantation, according to a presentation.

Post-liver transplant recipients who were fully vaccinated against COVID-19 saw a decrease in COVID-19 infection or death, according to a presentation at The Liver Meeting Digital Experience.

More than 40% of hepatology providers said burnout during the COVID-19 negatively impacted their well-being, including work fulfillment and satisfaction, according to a presentation at The Liver Meeting Digital Experience.

Early in the COVID-19 era, liver transplantation decreased overall with a lower graft survival at 90-day post-transplantation and higher organ rejection rate, according to a presentation at The Liver Meeting Digital Experience.

Terns Pharmaceuticals announced positive top-line results from a phase 1 clinical trial of TERN-501, a thyroid hormone receptor beta agonist for the treatment of nonalcoholic steatohepatitis, according to a press release.

Adults with nonalcoholic steatohepatitis and obesity have a much lower risk for a major adverse liver outcome or major adverse cardiovascular event if they undergo bariatric surgery vs. nonsurgical treatment, according to study data.

The AGA published clinical practice guidelines in Gastroenterology for the management of coagulation disorders among patients with cirrhosis.

Healio Gastroenterology presents the following report on the top 10 peer-tested stories from the ACG Annual Scientific Meeting 2021.

The FDA granted fast track designation to LPCN 1144 as a treatment for non-cirrhotic nonalcoholic steatohepatitis, according to a release from Lipocine.

The CDC’s Advisory Committee on Immunization Practices voted unanimously, 15-0, on Wednesday to recommend hepatitis B vaccination for all adults aged 19 to 59 years.